Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Atila GUNGOR"'
Autor:
Gizem ISSIN, Zafer KUCUKODACI, Ismail YILMAZ, Evren ERKUL, Ersin TURAL, Dilaver DEMIREL, Atila GUNGOR, Sukru YILDIRIM
Publikováno v:
Türk Patoloji Dergisi, Vol 37, Iss 2, Pp 106-114 (2021)
Objective: Although squamous cell carcinomas (SCCs) originating from different anatomic localizations display a similar histological appearance under light microscopy, they may differ in terms of epigenetic and genetic features. The aim of this study
Externí odkaz:
https://doaj.org/article/0a4a132949fa4a48ab1e0345700cd2ff
Autor:
Gizem Issin, Enver Cesmeci, Ismail Yilmaz, Atila Gungor, Evren Erkul, Engin Cekin, Ersin Tural
Publikováno v:
Hamidiye Medical Journal. 1:101-105
Publikováno v:
Cytopathology. 31:26-34
BACKGROUND Invasive diagnostic methods, such as punch biopsies, have a potential to produce undesirable side effects in the larynx, such as scarring and vocal dysfunction. This study is an attempt to assess the diagnostic potential of cytology to eff
Publikováno v:
Turkish Archives of Otorhinolaryngology, Vol 57, Iss 2, Pp 75-80 (2019)
Objective We aimed to present the long-term outcomes and sialendoscopic findings in only patients with sialolithiasis and ductal scars in idiopathic chronic recurrent sialadenitis who experienced unsuccessful results with conservative treatment and w
Autor:
Zafer Kucukodaci, Atila Gungor, Evren Erkul, Ersin Tural, Ismail Yilmaz, Gizem Issin, Sukru Yildirim, Dilaver Demirel
Publikováno v:
Türk Patoloji Dergisi, Vol 37, Iss 2, Pp 106-114 (2021)
Objective Although squamous cell carcinomas (SCCs) originating from different anatomic localizations display a similar histological appearance under light microscopy, they may differ in terms of epigenetic and genetic features. The aim of this study
Autor:
Zafer Kucukodaci, Onuralp Kurt, Salim Dogru, Murat Salihoglu, Enver Cesmeci, Halil Caliskan, Atila Gungor
Publikováno v:
Brazilian Journal of Otorhinolaryngology, Volume: 84, Issue: 3, Pages: 332-337, Published: JUN 2018
Brazilian Journal of Otorhinolaryngology v.84 n.3 2018
Brazilian Journal of Otorhinolaryngology
Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial (ABORL-CCF)
instacron:ABORL-CCF
Brazilian Journal of Otorhinolaryngology v.84 n.3 2018
Brazilian Journal of Otorhinolaryngology
Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial (ABORL-CCF)
instacron:ABORL-CCF
Introduction: Boric acid, which has antiseptic and acidic properties, is used to treat external and middle ear infections. However, we have not found any literature about the effect of boric acid powder on middle ear mucosa and inner ear. Objective:
Autor:
Mustafa Alparslan Babayigit, Atila Gungor, Gizem Narli, Dilaver Demirel, Ismail Yilmaz, Evren Erkul
Publikováno v:
European Archives of Oto-Rhino-Laryngology. 274:2921-2926
The aim of the present study was to evaluate the role of HPV in laryngeal squamous cell carcinoma and correlate it with patients’ clinicopathological data. In total, 78 laryngeal squamous cell carcinoma patients enrolled in this study. The presence
Publikováno v:
The Laryngoscope. 127:E62-E66
Objectives/Hypothesis We aimed to determine the microRNA-21 expression in laryngeal squamous cell carcinoma and assess the association between the disease and clinical characteristics of patients. Study Design Retrospective case-control study. Method
Autor:
Atila Gungor, Mesut Mutluoglu, Murat Konak, Volkan Arisan, Hakan Cincik, Murat Salihoglu, Zafer Kucukodaci, Evren Erkul, Engin Cekin, Sevim Ozdemir
Publikováno v:
European Archives of Oto-Rhino-Laryngology. 273:4501-4506
WOS: 000387700400056 PubMed ID: 27324888 This study was aimed to evaluate the efficacy of treatment modalities for minimizing salivary gland damage caused by radiotherapy. Forty rats were divided into five groups. Group 1 had no irradiation or any tr
Autor:
Mustafa Alparslan Babayigit, Zafer Kucukodaci, Dogan Pinar, Atila Gungor, Hakan Cincik, Evren Erkul, Onuralp Kurt
Publikováno v:
Head & Neck. 38:E535-E541
Background Tumor necrosis factor–related associated-inducing ligand (TRAIL) is a death ligand currently under clinical trials for laryngeal carcinoma. Methods Paraffin-embedded tissues from 40 patients with laryngeal carcinoma and 20 patients with